Xencor Inc
0.00 (0.0%)
Company Name Stock Ticker Symbol Market Type
Xencor Inc XNCR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 28.03 04:00:00
Open Price Low Price High Price Close Price Prev Close
more quote information »

Recent News

Date Time Source Heading
3/29/20232:01IHNWFeatured1606 Corp Announces Pivotal Distribution Deal With a Premier CBD Distributor
3/14/202316:31BWXencor to Present Preclinical Data from Novel XmAb® CD28..
3/13/202319:49EDGARStatement of Changes in Beneficial Ownership (4)
3/13/202319:46EDGARStatement of Changes in Beneficial Ownership (4)
3/13/202319:45EDGARStatement of Changes in Beneficial Ownership (4)
3/13/202319:43EDGARStatement of Changes in Beneficial Ownership (4)
3/13/202319:41EDGARStatement of Changes in Beneficial Ownership (4)
3/13/202306:04EDGARCurrent Report Filing (8-k)
3/09/202317:12EDGARReport of Proposed Sale of Securities (144)
3/06/202317:29EDGARReport of Proposed Sale of Securities (144)
3/03/202315:56EDGARReport of Proposed Sale of Securities (144)
2/28/202316:44EDGARCurrent Report Filing (8-k)
2/27/202308:22EDGARAutomatic Shelf Registration Statement of Securities of..
2/23/202316:29EDGARCurrent Report Filing (8-k)
2/23/202316:01BWXencor Reports Fourth Quarter and Full Year 2022 Financial..
2/16/202316:01BWXencor to Report Fourth Quarter and Full Year 2022 Financial..
2/16/202314:53EDGARAnnual Statement of Changes in Beneficial Ownership (5)
2/14/202312:52EDGARStatement of Ownership (sc 13g)
2/14/202312:41EDGARAmended Statement of Ownership (sc 13g/a)
2/09/202312:47EDGARAmended Statement of Ownership (sc 13g/a)
2/07/202316:01BWXencor to Present at the SVB Securities Global Biopharma..
2/06/202316:13EDGARStatement of Ownership (sc 13g)
1/24/202314:01EDGARAmended Statement of Ownership (sc 13g/a)
1/09/202308:01BWXencor Highlights 2023 Corporate Priorities and Provides..
1/05/202306:30PRNUSCaris Life Sciences and Xencor Expand Target Discovery..
1/04/202316:01BWXencor to Present at the 41st Annual J.P. Morgan Healthcare..
12/21/202218:47EDGARStatement of Changes in Beneficial Ownership (4)
12/12/202210:00BWXencor Presents Data from Phase 1 Study of Plamotamab in..
12/08/202211:51EDGARAmended Statement of Ownership (sc 13g/a)
11/13/202222:57TRMNXencor (XNCR) Gets a Buy from SVB Securities
11/10/202216:01BWXencor to Present at Upcoming Investor Conferences
11/10/202211:57EDGARAmended Statement of Ownership (sc 13g/a)
11/10/202209:01BWXencor Presents Early Clinical Data from Combination Study..
11/08/202209:50TRMNAnalysts Have Conflicting Sentiments on These Healthcare..
11/08/202207:40TRMNAnalysts Offer Insights on Healthcare Companies: Cigna (CI),..
11/08/202206:15TRMNBerenberg Bank Sticks to Their Buy Rating for Xencor (XNCR)
11/07/202223:25TRMNMizuho Securities Remains a Buy on Xencor (XNCR)
11/07/202217:26EDGARQuarterly Report (10-q)
11/07/202216:33EDGARCurrent Report Filing (8-k)
11/07/202216:01BWXencor Reports Third Quarter 2022 Financial Results
11/03/202213:55TRMNMizuho Securities Keeps Their Buy Rating on Xencor (XNCR)
11/03/202209:01BWXencor to Present New Clinical Data from the Phase 1 Study..
10/31/202216:01BWXencor to Host Third Quarter 2022 Financial Results Webcast..
10/06/202220:37TRMN‘Take Opportunities on Days Like Today’: Mary Callahan..
10/05/202208:01BWXencor to Present Seven Posters on Multiple Clinical Trials..
9/09/202216:23EDGARStatement of Changes in Beneficial Ownership (4)
9/09/202216:12EDGARInitial Statement of Beneficial Ownership (3)
9/09/202208:06EDGARCurrent Report Filing (8-k)
9/09/202208:01BWXencor Appoints Nancy Valente, M.D., to Board of Directors
8/12/202204:20TRMNAnalysts Are Bullish on These Healthcare Stocks: Xencor..
8/04/202223:19TRMNXencor (XNCR) Received its Third Buy in a Row